Low-vision intervention for oculocutaneous albinism in a Tertiary Eye Care Hospital in India.

Saudi J Ophthalmol

Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.

Published: March 2023

Purpose: The objective of this study on patients with albinism in different age groups was to compare their level of visual impairment with the low-vision intervention (LVI) and its benefit.

Methods: The medical records of 72 patients with low vision secondary to albinism who were referred to the low vision care clinic from 2015 to 2017 were analyzed. This included the demographic profile such as age, gender, occupation, ocular history, visual acuity status, and type of low-vision device (LVD) preferred. The LVDs prescribed and its subsequent improvement was compared.

Results: In this data, 70 (97.2%) people had oculocutaneous albinism and 2 (2.8%) had ocular albinism. Majority of the patients had hyperopic astigmatism 42 (58.3%) and with-the-rule astigmatism 58 (93.5%). Presenting mean visual acuity for distance was noted to be 0.88 logMAR which improved to 0.83 logMAR with the help of spectacle correction. The most commonly prescribed LVD was a dome magnifier for 15 (34.9%) patients. In all the patients, there was statistically significant improvement ( < 0.05) in near vision with the help of LVDs.

Conclusion: The study highlights the importance of appropriate LVI for each subdivided age group. Patients with albinism who have received medical and surgical treatment have no or a limited role in restoring useful vision.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032282PMC
http://dx.doi.org/10.4103/sjopt.sjopt_266_21DOI Listing

Publication Analysis

Top Keywords

low-vision intervention
8
oculocutaneous albinism
8
patients albinism
8
low vision
8
visual acuity
8
albinism
6
patients
6
intervention oculocutaneous
4
albinism tertiary
4
tertiary eye
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!